Your browser doesn't support javascript.
loading
Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor.
Kwan, Suet-Ying; Slayden, Alyssa N; Coronado, Aubrey R; Marquez, Rosamaria C; Chen, Huiqin; Wei, Peng; Savage, Michelle I; Vornik, Lana A; Fox, Jennifer T; Sei, Shizuko; Liang, Dong; Stevenson, Heather L; Wilkerson, Gregory K; Gagea, Mihai; Brown, Powel H; Beretta, Laura.
Afiliação
  • Kwan SY; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Slayden AN; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Coronado AR; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Marquez RC; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chen H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wei P; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Savage MI; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vornik LA; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fox JT; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland.
  • Sei S; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland.
  • Liang D; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas.
  • Stevenson HL; Department of Pathology, The University of Texas Medical Branch, Galveston, Texas.
  • Wilkerson GK; Keeling Center for Comparative Medicine and Research, University of Texas, MD Anderson Cancer Center, Bastrop, Texas.
  • Gagea M; Department of Veterinary Medicine & Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Brown PH; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Beretta L; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Prev Res (Phila) ; 16(1): 17-28, 2023 01 04.
Article em En | MEDLINE | ID: mdl-36162136
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatopatia Gordurosa não Alcoólica / Neoplasias Hepáticas Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatopatia Gordurosa não Alcoólica / Neoplasias Hepáticas Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article